Article

Biocompatible fluorescence-enhanced ZrO₂-CdTe quantum dot nanocomposite for in vitro cell imaging.

School of Chemical and Biomedical Engineering, Nanyang Technological University, 70 Nanyang Drive, 637457 Singapore.
Nanotechnology (Impact Factor: 3.67). 04/2011; 22(15):155604. DOI: 10.1088/0957-4484/22/15/155604
Source: PubMed

ABSTRACT With advances of quantum dots (QDs) in bioimaging applications, various materials have been used to coat QDs to reduce their nanotoxicity; however, the coating could introduce new toxic sources and quench the fluorescence in bioimaging applications. In this work, ZrO₂, an excellent ceramic material with low extinction coefficient and good biocompatibility, is utilized to coat CdTe QDs for the first time. Experimental results show that ZrO₂-QD nanocomposites with the size of ~30 nm possess enhanced fluorescence emission, lower nanotoxicity and gradually increased fluorescence under 350 nm light illumination. After functionalization with folic acid, they were applied to label cultured HeLa cells effectively. Therefore, the ZrO₂-QD nanocomposites could be promising biocompatible nanomaterials with strong fluorescence emission to replace or complement QDs in biomedical applications.

0 Bookmarks
 · 
98 Views
  • [Show abstract] [Hide abstract]
    ABSTRACT: An efficient and biocompatible drug nanocarrier is essential for nanomedicines to realize their full therapeutic potential. Here, we investigate the loading of a selective and potent anticancer drug, β-lapachone (β-lap), on a magnetite nanoparticle-decorated reduced graphene oxide (Fe(3)O(4)/rGO) and the in vitro anticancer efficacy of β-lap loaded Fe(3)O(4)/rGO. Reduced graphene oxide (rGO) with magnetic functionality was prepared via electrostatic interaction between positively charged magnetite (Fe(3)O(4)) nanoparticles and negatively charged GO, followed by hydrazine reduction of GO to rGO. The prepared Fe(3)O(4)/rGO shows that Fe(3)O(4) makes the Fe(3)O(4)/rGO hybrid magnetically separable for easy handling during drug loading and release and the Fe(3)O(4)/rGO hybrid exhibits significantly higher loading capacity than that of Fe(3)O(4)/GO, suggesting that restoration of the graphene basal plane upon reduction of GO enhances the interaction between β-lap and rGO. Cellular uptake studies using fluorescently labeled Fe(3)O(4)/rGO verifies successful internalization of Fe(3)O(4)/rGO into the cytoplasm while rGO without hybridized Fe(3)O(4) has poor uptake performance. Furthermore, β-lap loaded Fe(3)O(4)/rGO shows remarkably high cytotoxicity toward MCF-7 breast cancer cells while the blank Fe(3)O(4)/rGO produces no cytotoxic effects. The cytotoxicity results suggest that Fe(3)O(4)/rGO is an efficient drug carrier for anticancer treatments. The fine-tuning of the chemical structures of graphene oxides by reduction chemistry may provide a universal route for controlled loading and release of drugs or biomolecules to construct advanced delivery vehicles.
    Molecular Pharmaceutics 03/2012; 9(3):615-21. · 4.57 Impact Factor
  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: The use of an "over 1000-nm near-infrared (NIR) in vivo fluorescence bioimaging" system based on lanthanide containing inorganic nanostructures emitting in the visible and NIR range under 980-nm excitation is proposed. It may overcome problems of currently used biomarkers including color fading, phototoxicity and scattering. Gd(2)O(3):Er(3+),Yb(3+) nanoparticles and nanorods showing upconversion and NIR emission are synthesized and their cytotoxic behavior is investigated by incubation with B-cell hybridomas and macrophages. Surface modification with PEG-b-PAAc provides the necessary chemical durability reducing the release of toxic Gd(3+) ions. NIR fluorescence microscopy is used to investigate the suitability of the nanostructures as NIR-NIR biomarkers. The in vitro uptake of bare and modified nanostructures by macrophages is investigated by confocal laser scanning microscopy. In vivo investigations revealed nanostructures in liver, lung, kidneys and spleen a few hours after injection into mice, while most of the nanostructures have been removed from the body after 24 h.
    Journal of Materials Science Materials in Medicine 05/2012; 23(10):2399-412. · 2.14 Impact Factor
  • [Show abstract] [Hide abstract]
    ABSTRACT: Lanthanide-doped luminescent nanoscale materials have great potential applications in biological researches. Herein, we reported a novel and mild method for one-step synthesis of chitosan/NaGdF4:Eu3+ nanocomposites. The luminescent Eu3+ ions and magnetic resonance imaging (MRI) contrast agent Gd3+ ions were incorporated to these biocompatible nanocomposites. The resultant nanocomposites exhibited strong fluorescence and attractive magnetic features. The nanocomposites also have pure hexagonal phase with uniform size of about 65 nm. FT-IR spectra revealed that these nanocomposites were successfully coated by hydrophilic chitosan, whose amine groups conferred the nanocomposites excellent dispensability in aqueous solution. Besides, the MTT assay and laser confocal microscopy images have confirmed the good biocompatibility of the nanocomposites. These results indicated that the as-prepared nanocomposites could be used as an excellent targeted imaging agent in biological fields.
    Nano brief reports and reviews 02/2014; 09(01). · 1.26 Impact Factor